BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 22, 2003
View Archived Issues
Adenosine alleviates neuropathic pain in humans
Read More
Advantages for insulin/metformin vs. triple oral therapy in type 2 diabetes
Read More
Pentostatin in children with chronic GVHD
Read More
HDAC inhibitors reported to be potentially useful in controlling cardiac hypertrophy
Read More
Antiinflammatory effects described for IS-741 in a rat model of IBD
Read More
AVI BioPharma cleared to begin phase Ib trial of West Nile virus antisense drug
Read More
Abbott and Millennium end research alliance
Read More
Health Canada approves Gamunex
Read More
SuperGen discusses Orathecin rolling NDA submission plans with FDA
Read More
Genta to acquire Salus Therapeutics
Read More
Preliminary results of North American Cystistat trial for interstitial cystitis
Read More
Corixa and Apovia enter RC-529 agreement
Read More
Engitech to commercialize and market Alferon N in the U.S.
Read More
ImClone submits Erbitux BLA
Read More
Substance P-derived peptides with NK1-antagonist activity and their use as antitumor agents
Read More
Quinazoline-based fungal efflux pump inhibitors newly developed at Essential Therapeutics
Read More
Eisai claims novel proteasome inhibitors with utility as antitumor agents
Read More
Novel PPARalpha agonists under study at Sigma-Tau
Read More
New MMP inhibitors in early development at Leo Pharma
Read More